expand_moreexpand_less
Aeon
Al Jazeera
América Economía
Blitz
Buenos Aires Herald
Deutsche Welle
Dnevnik
E-International
Haaretz
Il Manifesto Global
Japan Today
Khaama PressMiddle East Monitor
New Eastern OutlookNikkei Asian ReviewOped Column
Pravda.sk
Project Syndicate
Psychology TodayRT.comSME.sk
South China Morning PostThe Asahi ShimbunThe DiplomatThe Japan NewsThe Japan Times
The Korea TimesThe Times of IsraelThe Times of Israel (Blogs)Večer
العين الإخبارية 
Toi StaffEmanuel FabianJacob MagidAgenciesReuters
Gideon LevyDavid HorovitzThe Japan News EditorialLazar BermanLuke TressGianluca PacchianiAmérica EconomíaRon KampeasRenee Ghert-ZandCathryn J. PrinceOthman Moqbel
Belen Fernandez
Andrew MitrovicaThe Asahi ShimbunJeremy SharonSam SokolAmanda Borschel-DanCharlie SummersElana KirshAmira HassCarolina LandsmannZvi Bar&x27El
Mort LaitnerSue SurkesAmy SpiroNatan OdenheimerYuli TamirBradley BlankenshipStephen GrovesEran Yashiv
Rami G Khouri
Ali Fathollah-NejadSlavoj ŽižekCanaan LidorRachel MarsdenNoa LandauEfrat Rayten
Nikkei EditorialWilliam Noah GlucroftShalom YerushalmiJames ShimanyulaAbbas JumaMegan KangJapan TodayE-International Relations
|
|
Randall Lutter, Opinion ContributorThe Hill |
The key to improving pandemic preparedness in the U.S. is not simply additional funding, but also better management of federal resources.
Congress should step in to demand FDA do more to explain its actions to avoid and mitigate shortages, and to increase supplies.
login
who are we?
contact us
qosheapp
